Type
Internal restructuring
Country
Spain
Region
Location of affected unit(s)
Sector
Manufacturing
Manufacture Of Chemicals And Pharamceuticals
Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations
21.1 - Manufacture of basic pharmaceutical products

225 jobs
Number of planned job losses
Job loss
Announcement Date
27 May 2013
Employment effect (start)
28 May 2013
Foreseen end date

Description

Pharmaceutical manufacturer Esteve will apply for a redundancy procedure (ERE) affecting 225 employees from its pharmaceutical division (15% of its entire workforce). The measure is attributed to a drop in the revenues recorded in this area. Before the company applied for the ERE, the restructuring started with around 90 job losses via early retirement schemes and non-renewal of temporary contracts.


Sources

  • 27 May 2013: Expansión

Citation

Eurofound (2013), Esteve, Internal restructuring in Spain, factsheet number 75459, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/75459.